We are live on
!
Find out more
MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.5B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+9.94%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$24.1B
AUM Growth
-$134M
(-0.56%)
Cap. Flow
-$2.11B
Cap. Flow
% of AUM
-8.76%
Top 10 Holdings %
Top 10 Hldgs %
23.77%
Holding
1,984
New
527
Increased
347
Reduced
445
Closed
587
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$157M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$135M |
| 3 |
Salesforce
CRM
|
+$135M |
| 4 |
IBM
IBM
|
+$130M |
| 5 |
Dell
DELL
|
+$114M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$313M |
| 2 |
Apple
AAPL
|
+$207M |
| 3 |
Intel
INTC
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$159M |
| 5 |
Centene
CNC
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.31% |
| 2 | Technology | 17.95% |
| 3 | Communication Services | 13.61% |
| 4 | Consumer Discretionary | 12.67% |
| 5 | Financials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Canadian Natural Resources
CNQ
$93.8B
| $17.8M | 0.07% |
1,002,714
-1,419,123
| -59% | -$23.4M |
|
277
Concentrix
CNXC
$1.57B
| $17.7M | 0.07% |
110,200
+102,350
| +1,304% | +$15.7M |
|
278
PVH
PVH
$4.04B
| $17.6M | 0.07% |
163,879
+27,479
| +20% | +$3.02M |
|
279
Realty Income
O
$59.1B
| $17.5M | 0.07% |
271,160
+62,643
| +30% | +$4.12M |
|
280
AvalonBay Communities
AVB
$26.8B
| $17.4M | 0.07% |
83,295
+62,026
| +292% | +$12.4M |
|
281
Semtech
SMTC
$13B
| $17.4M | 0.07% |
252,637
+224,139
| +787% | +$14.8M |
|
282
Datadog
DDOG
$84B
| $17.3M | 0.07% |
166,000
| – | – |
|
283
Eli Lilly
LLY
$1.06T
| $17.3M | 0.07% |
75,194
+72,456
| +2,646% | +$14.6M |
|
|
ARNA
284
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $17.2M | 0.07% |
252,748
-74,310
| -23% | -$4.84M |
|
285
Toyota
TM
$225B
| $17.1M | 0.07% |
97,654
-10,134
| -9% | -$1.66M |
|
286
American Express Global Business Travel
GBTG
$4.94B
| $16.8M | 0.07% |
1,718,535
| – | – |
|
287
Domino's
DPZ
$11.6B
| $16.7M | 0.07% |
35,816
-13,134
| -27% | -$5.57M |
|
|
SAGE
288
DELISTED
Sage Therapeutics
SAGE
| $16.6M | 0.07% |
291,989
-169,712
| -37% | -$12M |
|
289
Allstate
ALL
$67.5B
| $16.5M | 0.07% |
126,551
-107,106
| -46% | -$13.8M |
|
290
F5
FFIV
$22.7B
| $16.5M | 0.07% |
88,371
+16,368
| +23% | +$3.15M |
|
291
Caterpillar
CAT
$387B
| $16.4M | 0.07% |
75,521
+12,312
| +19% | +$2.84M |
|
292
Exelon
EXC
$47B
| $16.4M | 0.07% |
520,086
+327,762
| +170% | +$10.6M |
|
293
Match Group
MTCH
$8.55B
| $16.4M | 0.07% |
101,680
-184,840
| -65% | -$27.1M |
|
294
Olin
OLN
$2.12B
| $16.1M | 0.07% |
347,168
+270,782
| +354% | +$12.2M |
|
295
Star Bulk Carriers
SBLK
$3.22B
| $16M | 0.07% |
695,775
+298,850
| +75% | +$5.91M |
|
|
296
Intel
INTC
$513B
| $15.8M | 0.07% |
282,133
-3,124,541
| -92% | -$183M |
|
297
United Parks & Resorts
PRKS
$2.12B
| $15.6M | 0.06% |
+312,777
| New | +$16.6M |
|
298
Amgen
AMGN
$222B
| $15.6M | 0.06% |
63,921
+60,540
| +1,791% | +$14.9M |
|
|
SKX
299
DELISTED
Skechers
SKX
| $15.5M | 0.06% |
+310,515
| New | +$14.6M |
|
300
Waste Management
WM
$91B
| $15.5M | 0.06% |
+110,380
| New | +$15.3M |
|
Similar funds
TGHSA
PAM
HB
MWA
3SCA
HFCIV
DVC
NAM
Marshall Wace North America's Q2 2021 Portfolio in Review
As of Q2 2021, Marshall Wace North America held 1,984 positions worth $24.1B, down 0.56% from $24.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Marshall Wace North America withdrew a net $2.11B in Q2 2021, closing 587 positions and reducing 445 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $119M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Marshall Wace North America opened a new position in Syneos Health, Inc. Class A Common Stock worth $83.7M.
- Marshall Wace North America's largest Q2 2021 buy was Syneos Health, Inc. Class A Common Stock: 935,304 shares worth $83.7M.
- Marshall Wace North America added most to Johnson & Johnson in Q2 2021, an estimated $157M increase.
- Marshall Wace North America's biggest Q2 2021 reduction was Microsoft, cutting an estimated $313M.
- Marshall Wace North America fully exited State Street SPDR S&P 500 ETF Trust in Q2 2021, selling an estimated $119M.
- Marshall Wace North America's ten largest holdings make up 24% of its $24.1B portfolio in Q2 2021.
- Marshall Wace North America opened 527 new positions and closed 587 in Q2 2021.
- Marshall Wace North America's portfolio value fell 0.56% quarter-over-quarter to $24.1B.
Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.